 2. Diagnostic criteria: Patients must have had a previous histological verification of a solid tumor at the original diagnosis andor recurrence including brain tumors. For patients with brain stem gliomas and optic pathway tumors, the requirement for histological evaluation may be waived. The patients disease must be considered refractory to conventionalstandard therapy, or a disease for which no conventional therapy exists and is progressive. 